Drugplain

MESALAMINE .375 g/1

MESALAMINE · CAPSULE, EXTENDED RELEASE · Alembic Pharmaceuticals Limited

No Recall History
Plain English

MESALAMINE is a capsule, extended release containing mesalamine at .375 g/1, taken oral. Manufactured by Alembic Pharmaceuticals Limited.

Key Facts

Brand Name
MESALAMINE
Generic Name
MESALAMINE
NDC Code (Product)
46708-724
Manufacturer
Alembic Pharmaceuticals Limited
Strength
.375 g/1
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing Status
Application #
ANDA216967
Drug Class
Aminosalicylate [EPC]
Marketing Start
11/03/2022

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

off label use6,239 reports
colitis ulcerative4,341 reports
drug ineffective4,187 reports
condition aggravated3,232 reports
diarrhoea2,508 reports
haematochezia2,348 reports
fatigue2,108 reports
abdominal pain2,075 reports
weight decreased1,816 reports
headache1,783 reports

Frequently Asked Questions

What is MESALAMINE used for?

MESALAMINE contains MESALAMINE. It is a capsule, extended release taken oral. Consult your doctor for specific uses.

Is MESALAMINE a controlled substance?

MESALAMINE is not classified as a controlled substance by the DEA.

What is the generic name for MESALAMINE?

The generic name for MESALAMINE is MESALAMINE. There are 11 other brand versions of MESALAMINE.

What is the NDC code for MESALAMINE .375 g/1?

The NDC (National Drug Code) for MESALAMINE .375 g/1 is 46708-724, listed by Alembic Pharmaceuticals Limited.

Product NDC

46708-724

Package NDC

46708-724-35

Other MESALAMINE Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)